Abstract :
[en] Platelet rich plasma (PRP), a platelet concentrate obtained by centrifugation of autologous blood, has many properties that promote hemostasis and tissue healing. While its clinical effect is still being discussed today, PRP is increasingly used in the context of tendinopathies resistant to conventional treatments. In order to resume the practice of sports under optimal conditions, a Decision-Based RTP Model has recently been proposed. We will discuss the different criteria of return to play and risk factors involved in order to optimize the return to play and effectiveness of this treatment with PRP. © 2019 Elsevier Masson SAS
Scopus citations®
without self-citations
1